findmyKOL
Clinical trialNCT05130255TerminatedPhase 1Interventional

GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2

SponsorY-mAbs TherapeuticsEnrollment23High Risk NeuroblastomaMalignant MelanomaSCLCSarcoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Honorhealth

    Scottsdale, Arizona, United States

  • City of Hope National Medical Center

    Duarte, California, United States

  • University of Chicago

    Chicago, Illinois, United States

  • Corewell Health-Bamf Health

    Grand Rapids, Michigan, United States

  • Memorial Sloan- Kettering Cancer Center

    New York, New York, United States

  • Case Western Reserve University, Cleveland

    Cleveland, Ohio, United States

  • Upmc Hillman Cancer Center

    Pittsburgh, Pennsylvania, United States

  • University of Wisconsin-Madison

    Madison, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
17 Nov 2022
Primary completion
11 Mar 2026
Completion
11 Mar 2026
Last update posted
18 Jun 2026
Registered enrollment
23
Registry id
NCT05130255

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.